dc.contributor.author | Rezapour, S | |
dc.contributor.author | Bahrami, T | |
dc.contributor.author | Hashemzadeh, S | |
dc.contributor.author | Estiar, MA | |
dc.contributor.author | Nemati, M | |
dc.contributor.author | Ravanbakhsh, R | |
dc.contributor.author | Feizi, MAH | |
dc.contributor.author | Kafil, HS | |
dc.contributor.author | Pouladi, N | |
dc.contributor.author | Ghojazadeh, M | |
dc.contributor.author | Sakhinia, E | |
dc.date.accessioned | 2018-08-26T09:36:19Z | |
dc.date.available | 2018-08-26T09:36:19Z | |
dc.date.issued | 2016 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/57972 | |
dc.description.abstract | Background: Stanniocalcin-1 (STC1) and nuclear factor (NF)-RB subunit p65 transcription factor are involved in various types of human malignancies. The roles of STC1 and NFRB-p65 in colorectal cancer (CRC) are still not fully understood. We investigated expression levels of NF-RB p65 and STC1 and also correlations between STC1 and NF-RB p65 expression and clinicopathological features in CRC. Methods: Tumor tissue samples were collected from 48 patients with CRC. RT-PCR and Real-time PCR analysis was performed to examine mRNA levels of STC1 and NF-RB p65. Results: The relative mRNA levels of STC1 and NF-RB p65 were significantly higher in tumor tissues than in adjacent mucosa (p = 0.025 and p = 0.044, respectively). The data also showed that STC1 and NF-RB p65 mRNA levels were not significantly associated with clinicopathological characteristics. In addition, there was no association between expression levels of STC1 and NF-RB p65 in tumor samples. Conclusions: Our data indicate that STC1 and NF-KBp65 is activated constitutively in colorectal carcinoma tissues, suggesting that activation of these factors might play an important role in colorectal tumorigenesis. Future studies should examine STC1 and NF-?Bp65 as a molecular target for the treatment of CRC. | |
dc.language.iso | English | |
dc.relation.ispartof | Clinical Laboratory | |
dc.subject | hypocalcin | |
dc.subject | messenger RNA | |
dc.subject | stanniocalcin 1 | |
dc.subject | transcription factor RelA | |
dc.subject | unclassified drug | |
dc.subject | glycoprotein | |
dc.subject | hypocalcin | |
dc.subject | messenger RNA | |
dc.subject | transcription factor RelA | |
dc.subject | adult | |
dc.subject | aged | |
dc.subject | Article | |
dc.subject | cancer surgery | |
dc.subject | clinical article | |
dc.subject | colorectal cancer | |
dc.subject | controlled study | |
dc.subject | female | |
dc.subject | human | |
dc.subject | human tissue | |
dc.subject | male | |
dc.subject | molecular pathology | |
dc.subject | protein expression | |
dc.subject | real time polymerase chain reaction | |
dc.subject | reverse transcription polymerase chain reaction | |
dc.subject | Colorectal Neoplasms | |
dc.subject | genetics | |
dc.subject | metabolism | |
dc.subject | middle aged | |
dc.subject | pathology | |
dc.subject | Adult | |
dc.subject | Aged | |
dc.subject | Colorectal Neoplasms | |
dc.subject | Female | |
dc.subject | Glycoproteins | |
dc.subject | Humans | |
dc.subject | Male | |
dc.subject | Middle Aged | |
dc.subject | RNA, Messenger | |
dc.subject | Transcription Factor RelA | |
dc.title | STC1 and NF-?B p65 (Rel A) is constitutively activated in colorectal cancer | |
dc.type | Review | |
dc.citation.volume | 62 | |
dc.citation.issue | 3 | |
dc.citation.spage | 463 | |
dc.citation.epage | 469 | |
dc.citation.index | Scopus | |
dc.identifier.DOI | https://doi.org/10.7754/Clin.Lab.2015.150827 | |